Jesus E Millan Nunez-Cortes¹* and Joaquin J Millan Perez²
¹Department of Internal Medicine, General University Hospital Gregorio Maranon, Spain
²Unit of Vascular Risk and Lipids, School of Medicine of the Complutense, University of Madrid, Spain
Corresponding Author:
Jesus E Millan Nunez-Cortes, Department of Internal Medicine, General University Hospital Gregorio Maranon, Spain, Email: jesus.millan@salud. madrid.org
Abstract
Current scientific evidence indicates the association between the elevation of triglycerides (TG), the decrease the High Density Lipoprotein Cholesterol HDLC and the increase in cardiovascular risk.
Citation
Nunez-Cortes JEM and Perez JJM. Atherogenic Dyslipidemia as a Marker of Cardiometabolic Risk. SM J Endocrinol Metab. 2016;2(1):1010s.
